Pharmacokinetics and tolerability of single ascending doses of RGH 790 in male volunteers

Trial Profile

Pharmacokinetics and tolerability of single ascending doses of RGH 790 in male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Nov 2012

At a glance

  • Drugs RGH-790 (Primary)
  • Indications Psychotic disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Nov 2012 New trial record
    • 17 Oct 2012 Results presented at the 25th Annual Congress of the European College of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top